| Pharmaceutical active ingredients: |
| Oxymetazoline Hydrochloride |
| Available forms, composition and doses of Rino Calyptol: |
| N / A |
| Rino Calyptol medical category: |
| Human:Nasal decongestants and other nasal preparationsOphthalmic decongestants, anesthetics, anti-inflammatoriesVasoconstrictors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01AA05 - OxymetazolineR01AB07 - OxymetazolineS01GA04 - Oxymetazoline |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Rinizide | Isoniazid; Pyrazinamide; Rifampin | Lupin Pharmaceuticals |
| Rinizide Forte DT | Isoniazid; Pyrazinamide; Rifampin | Lupin Pharmaceuticals |
| Rinlac | Unidentified active ingredients | Neon Laboratories |
| Rinlaxer | Chlorphenesin Carbamate | Taisho Pharmaceutical |
| Rinnova | Calcium Glycerophosphate; Soya Isoflavones; Vitamin D3 (Cholecalciferol) | Sefarma |
| Rino Clenil | Beclomethasone Dipropionate | Chiesi; CNW Hong Kong; JDH Pharmaceutical; Multipharma, Netherlands |
| Rino Dexa | Chlorpheniramine Maleate; Dexamethasone Sodium Phosphate; Lysozyme Hydrochloride; Neomycin Sulfate | Sanofi-Aventis |
| Rino Ebastel | Ebastine; Pseudoephedrine Hydrochloride | Almirall |
| Rino Glucol Sulf | Ephedrine Hydrochloride; Sulfanilamide | Almirall |
| Rino Naftazolina | Naphazoline Hydrochloride | Bruschettini |